Document:

<PAGE>

                                                                   EXHIBIT 10(p)

                             PHANTOM STOCK AGREEMENT

      This PHANTOM STOCK Agreement ("Agreement") is made and entered into
effective as of January 15, 2000 by and between CORE MATERIALS CORPORATION, a
Delaware corporation (the "Company"), and James L. Simonton, an individual (the
"Executive"). The purpose of this Agreement is to provide to the Executive, who
is the President and Chief Executive Officer of the Company and is important to
the success and growth of the business of the Company, with certain benefits and
to help retain the services of the Executive. This Agreement will provide a
means whereby the Executive will be given an opportunity to share in the
appreciation of the Common Stock of the Company.

                                    ARTICLE I

                                   DEFINITIONS

      Section 1.01 As used in this Agreement, the following terms shall have the
meanings ascribed to them below:

      "Act" means the Securities Act of 1933, as amended.

      "Agreement" shall have the meaning set forth in the preamble hereof.

      "Base Value" means $2.75 per share of Common Stock.

      "Board" means the Board of Directors of the Company.

      "Committee" means the Compensation Committee of the Board.

      "Common Stock" means shares of the Company's Common Stock, $0.01 par
       value.

      "Company" shall have the meaning set forth in the preamble hereof.

      "Exchange Act" means the Securities Exchange Act of 1934, as amended.

      "Executive" shall have the meaning set forth in the preamble hereof.

      "Fair Market Value" means (i) if the Common Stock is then listed on a
national securities exchange, the closing sales price of the Common Stock on the
day such value is determined on the principal securities exchange on which such
stock is then listed, or if there is no reported sale on that day, the average
bid and asked quotations on such exchange on that day, or (ii) if the Common
Stock is then publicly traded in the National Market System of the NASDAQ Stock
Market, the closing sales price of the Common Stock as reported in the National
Market System of the NASDAQ Stock Market on the day such value is determined, or
if there is no reported sale on that day, the average of the bid and asked
quotations on that day, or (iii) if the Common Stock is then publicly traded in
the over-the-counter market on the day such value is determined, the average of
the bid and asked quotations on that day, or if no shares were traded that day,
on the next preceding day on which there was such a trade, or (iv) if the Common
Stock is not then separately quoted or publicly traded, the fair market value on
the date such value is to be determined, as determined in good faith by the
Committee.

      "Internal Revenue Code" means the Internal Revenue Code of 1986, as
amended.

      "Subsidiary Corporation" shall have the definition of a subsidiary
corporation contained in section 424 of the Internal Revenue Code.

      "Successor" means the legal representative of the estate of the Executive
or the person or persons who shall acquire the right to receive payment for a
Unit by bequest or inheritance or by reason of the death of the Executive.

      "Term" means the period during which a particularly Unit may be exercised.

                                       21
<PAGE>

      "Unit" means the right to receive, on the terms set forth in this
Agreement and during the Term, an amount equal to the excess of the Fair Market
Value of a share of the Common Stock on the date upon which the Executive
exercises his right to receive such payment over the Base Value.

                                   ARTICLE II

                         ADMINISTRATION OF THE AGREEMENT

      Section 2.01 This Agreement shall be administered on behalf of the Company
by the Committee; provided, however, that the Board, in lieu of the Committee,
shall have the right to take any action permitted or required hereunder to be
taken by the Committee.

      Section 2.02 The Committee shall adopt such rules of procedure as it may
deem proper; provided, however, that it may only take action upon the agreement
of a majority of the whole Committee. Any action which the Committee shall take
through a written instrument signed by all of its members shall be as effective
as though taken at a meeting duly called and held.

      Section 2.03 The powers of the Committee shall include plenary authority
to interpret this Agreement.

                                   ARTICLE III

                                 GRANT OF UNITS

      Section 3.01 The Company hereby grants to the Executive 150,000 Units
(subject to adjustment as provided in Article X hereof) effective as of the date
hereof.

                                   ARTICLE IV

                                VESTING OF UNITS

      Section 4.01 All Units granted hereunder shall vest on December 31, 2004.
No Units granted hereunder shall vest prior to such date.

      Section 4.02 Subsequent to the grant of any Unit, the Committee may
accelerate, at any time before such Unit becomes fully vested, the time or times
at which such Unit may be exercised.

      Section 4.03 Unless the Committee, in its sole discretion, permits
otherwise, Units granted under this Agreement shall be nontransferable other
than by will or by the laws of descent and distribution and a Unit may be
exercised during the lifetime of the Executive only by the Executive.

                                    ARTICLE V

                              TERMINATION OF A UNIT

      Section 5.01 Any Unit granted under this Agreement that has not been
exercised shall automatically and without notice terminate and become null and
void at the time of the earliest to occur of the following:

              (a)    December 31, 2005;

              (b)    The expiration of thirty (30) days from the date of
      termination (other than a termination described in Section 5.01(c) or on
      account of death or disability, as defined in Section 8.01, of the
      Executive while employed by the Company) of the Executive's employment
      with the Company or its Subsidiary Corporations or if the Executive shall
      die during such thirty-day period, the expiration of one (1) year
      following the date of the Executive's death; provided that no additional
      Units shall vest or become exercisable during the thirty (30) day or one
      (1) year period, as the case may be; and

                                       22
<PAGE>

            (c)   The date of termination of the Executive's employment with the
      Company or its Subsidiary Corporations, if such termination constitutes or
      is attributable to a breach by the Executive of an employment agreement
      with the Company or its Subsidiary Corporations or if the Executive is
      discharged for cause (it being agreed that the Committee shall have the
      right to determine whether or not the Executive has been discharged for
      cause and the date of such discharge, such determinations of the Committee
      to be final and conclusive).

                                   ARTICLE VI

               RIGHT TO TERMINATE EMPLOYMENT OR OTHER RELATIONSHIP

      Section 6.01 Nothing contained in this Agreement shall obligate the
Company or its Subsidiary Corporations to continue to employ or engage the
Executive as the President and Chief Executive Officer of the Company or in any
other capacity with the Company or its Subsidiary Corporations, nor confer upon
the Executive any right to continue in the employ of or in any other capacity
with the Company or its Subsidiary Corporations, nor limit in any way the right
of the Company or its Subsidiary Corporations to amend, modify or terminate the
Executive's compensation or employment agreement, if any, at any time.

                                   ARTICLE VII

                                EXERCISE OF UNITS

      Section 7.01 The Executive shall have the right and option to elect to be
paid for any then vested Units, at any time or from time to time prior to the
termination thereof, by the Executive timely delivering a written notice signed
by the Executive to the Chief Financial Officer of the Company at its principal
executive office stating therein that he has elected to exercise such right and
option and the number of vested Units for which the Executive is electing to be
paid. The date of exercise shall be the date the written notice is received by
the Company. The Company shall thereafter pay the Executive in complete
satisfaction of each Unit with respect to which such right and option has been
exercised in an amount equal to: (a) the Fair Market Value of a share of Common
Stock on the date of exercise of such right and option minus (b) the Base Value.
Such payment shall be made to the Executive within thirty (30) days after the
exercise of such right and option.

                                  ARTICLE VIII

                            TERMINATION OF EMPLOYMENT
                           DUE TO DEATH OR DISABILITY

      Section 8.01 Upon the termination of the employment of the Executive due
to the death or disability (within the meaning of Section 22(e)(3) of the
Internal Revenue Code) of the Executive while employed by the Company, (a) the
Company shall pay the Executive or his Successor, as the case may be, in
complete satisfaction of all fully vested and unexercised Units held by the
Executive on the date of termination of his employment, an amount determined in
the manner set forth in Article VII hereof as if the Executive had exercised the
right and option to be paid for all then fully vested and unexercised Units held
by the Executive on the date of such termination of the employment of the
Executive, and (b) all other Units held by the Executive on the date of such
termination of employment of the Executive shall terminate and shall become null
and void. Such payment shall be made by the Company to the Executive or his
Successor, as the case may be, within thirty (30) days after the date of such
termination of employment. The Committee shall have the right to determine
whether the Executive's termination is attributable to a disability of the
Executive within the meaning of Section 22(e)(3) of the Internal Revenue Code,
such determination of the Committee to be final and conclusive.

                                   ARTICLE IX

                              STOCKHOLDERS' RIGHTS

      Section 9.01 The Executive shall not have any rights of a stockholder by
virtue of the grant, vesting or exercise of a Unit.

                                       23
<PAGE>

                                    ARTICLE X

                                   ADJUSTMENTS

      Section 10.01 In the event that the shares of Common Stock shall be
changed into or exchanged for a different number or kind of shares of stock or
other securities of the Company or of another corporation (whether by reason of
merger, consolidation, recapitalization, reclassification, split-up, combination
of shares, or otherwise) or if the number of such shares of stock shall be
increased solely through the payment of a stock dividend, then there shall be
made an appropriate adjustment in the number of Units then held by the Executive
under this Agreement, in the Base Value (for purposes of Articles VII and VIII
of all then outstanding Units) and to the other terms under this Agreement as
may be necessary to reflect the foregoing events. In the event there shall be
any other change in the number or kind of the outstanding shares of Common Stock
of the Company, then if the Committee, in its sole discretion, determines that
such change equitably requires an adjustment in any Unit theretofore granted
under this Agreement, such adjustments shall be made in accordance with such
determination. The foregoing adjustments shall be made in a manner that will
cause the relationship between the aggregate appreciation in a share of Common
Stock and the increase in value of each Unit granted hereunder to remain
unchanged as a result of the applicable transaction.

      The Committee shall have the power, in the event of any merger or
consolidation of the Company with or into any other corporation, the merger of
consolidation of any other corporation into the Company, or the sale of all or
substantially all of the assets and business of the Company to another
corporation, to amend all outstanding Units so as to provide that (i) all Units
not then fully vested and exercisable shall become fully vested and exercisable
immediately prior to the effectiveness of any such merger, consolidation or sale
of assets and to terminate all Units upon the effectiveness of any such merger,
consolidation or sale of assets, and (ii) upon the effectiveness of any such
merger, consolidation or sale of assets, the Executive shall be paid the amount
provided in Article VII for all unexercised Units then held by him in the manner
provided in said Article VII as if the Executive had exercised his right and
option to be paid for all of such Units on the date of such effectiveness. In
such event, the Company shall give written notice of such amendment and
termination to the Executive of such Units prior to the effectiveness of any
such merger, consolidation or sale of assets. If the Committee shall exercise
such power and such merger, consolidation or sale of assets is consummated, all
Units then outstanding and subject to such requirement shall be deemed to have
been amended to provide for the vesting thereof prior to the effectiveness of
such merger, consolidation or sale of assets and such Units shall be deemed to
be exercised in full and shall terminate as of such date.

                                   ARTICLE XI

                                   WITHHOLDING

      Section 11.01 The Company shall have the right to deduct from all amounts
payable pursuant to this Agreement any taxes required by law to be withheld with
respect to such payment.

                                   ARTICLE XII

                               AGREEMENT UNFUNDED

      Section 12.01 The obligations of the Company under this Agreement at all
times shall be entirely unfunded and no provision shall at any time be made with
respect to segregating assets of the Company for payment of any benefits
hereunder. The Executive shall not have any interest in any particular asset of
the Company by reason of the right to receive a benefit under this Agreement and
the Executive shall have only the rights of a general unsecured creditor of the
Company with respect to his rights under this Agreement.

                                  ARTICLE XIII

                        ENTIRE AGREEMENT AND MODIFICATION

      Section 13.01 This Agreement supersedes all prior agreements between the
parties with respect to its subject matter and constitutes a complete and
exclusive statement of the terms of the agreement between the parties with
respect to its subject matter. Except as otherwise provided in Article X hereof,
this Agreement may not be amended except by written agreement executed by the
Company and the Executive.

                                       24
<PAGE>

      Section 13.02 The Units granted to the Executive under this Agreement have
not been granted to the Executive pursuant to the Company's Long-Term Equity
Incentive Plan and the provisions of such plan shall have no application to or
effect on this Agreement or the Units granted hereunder.

                                   ARTICLE XIV

                                  GOVERNING LAW

      Section 14.01 This Agreement shall be governed by the laws of the State of
Ohio without regard to conflicts of laws principles.

      IN WITNESS WHEREOF, the parties have executed and delivered this Agreement
as of the date first written above.

COMPANY:                                         EXECUTIVE:

CORE MATERIALS CORPORATION,
  a Delaware corporation

By: /s/ Malcolm M. Prine                         /s/ James L. Simonton
    --------------------                         ---------------------
Name: Malcolm M. Prine                           JAMES L. SIMONTON, individually
Title: Chairman of the Board

                                       25EMPLOYMENT AGREEMENT

         THIS EMPLOYMENT AGREEMENT (the "Agreement") is entered into on April
15, 2005, by I-TRAX, INC., a Delaware corporation with its principal business
offices located at 4 Hillman Drive, Suite 130, Chadds Ford, Pennsylvania 19317
(the "Company"), and RAYMOND J. FABIUS, an individual residing at 8 Frog Hollow
Drive, Newtown Square, Pennsylvania 19073 ("Executive").

         The Company desires to employ Executive, and Executive desires to be
employed by the Company on the terms set forth in this Agreement.

         In consideration of the mutual covenants and premises contained in this
Agreement, and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged by the Company and Executive, the
Company and Executive agree as follows:

         1. Term of Employment. Upon the terms set forth in this Agreement, the
Company employs Executive and Executive accepts employment with the Company for
the period commencing on May 16, 2005 and ending on May 16, 2008 (such period,
the "Original Term"), unless sooner terminated in accordance with the provisions
of Section 4 below. Upon the expiration of the Original Term, the term of
Executive's employment will automatically extend for additional terms of two
years each (each such period, an "Additional Term") on terms substantially
similar to this Agreement unless any Additional Term is sooner terminated in
accordance with the provisions of Section 4 below or unless on or before six
months prior to the end of the Original Term or any Additional Term, Executive
or the Company notifies the other in writing that Executive's employment under
this Agreement will not be extended beyond the Original Term or the applicable
Additional Term.

         2. Title and Capacity. Executive will serve as the President and Chief
Medical Officer of the Company, and will perform the duties commensurate with
such positions and such other duties as the Company's Board of Directors (the
"Board") or the Chairman may assign to Executive consistent with his position.
Executive will relinquish the position of the Chief Medical Officer when the
Company appoints a new chief medical officer, reasonably satisfactory to
Executive. Executive will devote attention and energies on a full-time basis to
the above duties, and Executive will not, during the term of this Agreement,
actively engage in any other for profit business activity, except Executive may,
so long as such activities do not violate the terms of Section 6.1 or impair
Executive's performance of his duties under this Agreement: (a) serve as a
director of up to two entities other than the Company, and (b) write, teach and
publish articles and books.

         3. Compensation and Benefits.

                  3.1      Salary and Bonus.

                           (a) During the Original Term, the Company will pay
Executive an annual base salary
of:

                                       1
<PAGE>

                           First year of Original Term:       $275,000
                           Second year of Original Term:      $312,500
                           Third year of Original Term:       $350,000

                           (b) During any Additional Term, the Company will pay
Executive an annual base salary mutually acceptable to Executive and the
Compensation Committee of the Board (the "Compensation Committee"), which will
not be less than $350,000.

                           (c) For each completed year of the Original Term and
any Additional Term, the Company will pay Executive a bonus of at least
$125,000. Any increase in the bonus will be determined in the sole discretion of
the Compensation Committee in accordance with the Company's annual bonus plan
and goals set for Executive consistent with those set for the Company's senior
executives generally. The bonus payment made under this Section 3.1(c) with
respect to any completed year will be referred to as a "Bonus."

                  3.2 Payment in Installments. The Company will pay Executive's
annual base salary in periodic installments in accordance with the Company's
general payroll practices, after withholding for all Federal, state and local
taxes and other required deductions. The Company will pay the Bonus within 90
days of completion of Executive's applicable year of employment.

                  3.3      Stock Options.

                           (a) On February 2, 2005, the date on which the Board
considered and approved the employment of Executive subject to the execution of
this Agreement, the Company approved the grant to Executive of options to
acquire 400,000 shares of the Company's common stock under the Company's 2001
Equity Compensation Plan (the "Plan Options"). The Plan Options will have a term
of ten years and will be first exercisable as follows: 100,000 shares on May 16,
2005; 100,000 shares on May 16, 2006; and the balance in eight equal, quarterly
installments beginning on August 16, 2006. Executive and Company will, upon
commencement of Original Term, determine the maximum number of shares that may
be subject to options granted as an "Incentive Options" as such term is defined
in the Company's 2001 Equity Compensation Plan (the "Equity Plan") and as set
forth in section 422 of the Internal Revenue Code of 1986, as amended (the
"Code") based on the fair market value of the Company's shares on that date and
the first exercise dates set forth above. The Incentive Options will have an
exercise price equal to that fair market value. All options not treated as
Incentive Options will be exercisable at $1.40 per share.

                           (b) The Plan Options will accelerate and be vested
and exercisable in full under the terms of the stock option agreement between
the Company and Executive for at least 12 months (a) if the Company terminates
Executive's employment under Section 4.3 for any reason other than for cause,
(b) if Executive terminates Executive's employment under Section 4.5(b) for good
reason, (c) in the event of Executive's death or "disability," as defined in the
Equity Plan or (d) in the event of a "Change in Control," as such term is
defined in the Equity Plan. Except as provided in this Section 3.3, the Plan
Options are in all respects subject to the terms of the Equity Plan and the
stock option agreement between the Company and Executive covering the Plan
Options.

                                       2
<PAGE>

                  3.4      Benefits.

                           (a) Provided Executive meets and continues to meet
the full-time and any and all other standard eligibility requirements set forth
in the Company's Employee Manual and benefits plans sponsored by the Company,
the Company will make available to Executive the standard full-time employee
benefits and benefit plans, and all executive perquisites, subject to employee
cost sharing provisions and other provisions of such benefits and benefit plans.
Notwithstanding the preceding, the Company may change, modify, amend, eliminate,
or terminate any benefit or benefit plan or change the employee cost sharing
provisions of any such benefit or benefit plan, and if the Company does so for
other senior executives, thereafter Executive will be entitled only to then
available standard full-time employee benefits and benefit plans.

                           (b) Executive may spend up to 10 days of each year of
the Original Term and any Additional Term attending continuing medical education
courses necessary to maintain medical licensure.

                  3.5 Paid Time Off. Executive is entitled to 20 paid time off
days per year to be accrued in accordance with the Company's policy, as amended
from time to time, and taken at such times as may be approved by the Chief
Executive Officer.

                  3.6      Expenses.

                           (a) The Company will reimburse Executive for all
reasonable travel, entertainment and other expenses incurred or paid by
Executive in connection with, or related to, the performance of his duties under
this Agreement in accordance with the Travel and Expense Policy published by the
Company's Finance Department for senior executives generally, as amended from
time to time.

                           (b) The Company will reimburse Executive for all
reasonable costs and expenses (including travel and lodging) of continuing
medical education courses necessary to maintain medical licensure.

                  3.7 Stock Purchase. Within 60 days of Executive's first date
of employment, Executive may purchase from the Company up to 120,000 shares of
the Company's common stock at a price of $1.25 per share. These shares will not
be subject to any restrictions other than those applicable under the Securities
Act of 1933, as amended, and the rules and regulations promulgated thereunder.

         4. Employment Termination. The employment of Executive by the Company
under this Agreement will terminate upon the occurrence of any of the following:

                  4.1 Expiration of Term. At the election of Executive or the
Company upon the expiration of the Original Term or any Additional Term if
Executive or the Company notified the other pursuant to Section 1 above that
Executive's employment under this Agreement will not be extended for an
Additional Term.

                                       3
<PAGE>

                  4.2 Cause. At the election of the Company, for "cause" as
defined below, immediately upon written notice by the Company to Executive,
except as provided below. "Cause" for termination is deemed to exist by reason
of (a) any action by Executive resulting in the conviction of Executive of, or
the entry of a plea of guilty or nolo contendere by Executive to, any crime
involving moral turpitude, any felony, or any misdemeanor involving misconduct
or fraud in business activities, (b) any breach of a fiduciary duty to the
Company involving personal profit, (c) Executive's willful misconduct, or
recklessness or gross negligence in the performance of his duties under this
Agreement, (d) any action by Executive that violates Section 6, or (e) repeated
refusals by Executive to comply with the reasonable directives of the Chief
Executive Officer of the Company or the Board that are consistent with his
position; provided, however, that the Company may terminate Executive's
employment under Sections 4.2 (d) or (e) above only after Executive fails (x) to
commence and continue to correct or cure each specific instance comprising cause
within 10 days of receipt by Executive of written notice of the Board
identifying each instance constituting cause or (y) to correct or cure each
identified instance within 45 days of receipt of such notice.

                  4.3 Without Cause. At the election of the Company, at any
time, upon 60 days written notice for any reason whatsoever other than for
cause.

                  4.4 Death or Disability. Upon Executive's death or 30 days
after Executive's disability. "Disability" means the inability of Executive, due
to a physical or mental disability, to perform the duties contemplated under
this Agreement for a period of 180 consecutive days. A physician satisfactory to
Executive and the Company will determine if Executive is disabled. If Executive
and the Company cannot agree on a physician within 30 days of either party's
written notice to the other, Executive and the Company will each select a
physician, who will together select a third physician. The determination of the
physician(s) as to disability will be binding on all parties.

                  4.5 Termination by Executive. At the election of Executive:
(a) at any time if his health should become impaired to an extent that makes the
continued performance of his duties under this Agreement hazardous to his
physical or mental health or his life, as certified by a physician designated by
Executive and reasonably acceptable to the Company; (b) for "good reason" upon
delivery of written notice of such "good reason" to the Company; or (c) upon 60
days written notice of termination. "Good reason" means: (1) the failure by the
Company to continue Executive in the position of President or Chief Medical
Officer of the Company (or such other senior executive position as may be
offered by the Company and which Executive may in his sole discretion accept);
(2) material diminution by the Chief Executive Officer of the Company or the
Board of Executive's responsibilities, duties, reporting relationships or
authority as President or Chief Medical Officer of the Company (or such other
senior executive position as may be offered by the Company and which Executive
may in his sole discretion accept) or assignment to Executive of any duties
inconsistent with Executive's position as President or Chief Medical Officer of
the Company (or such other senior executive position as may be offered by the
Company and which Executive may in his sole discretion accept); (3) failure by
the Company to pay and provide to Executive the compensation provided in Section
3.1 above, which failure is not cured within 30 days after written notice of

                                       4
<PAGE>

such failure is delivered by Executive to the Company; (4) requiring Executive
to be permanently based anywhere other than within 25 miles of his present home
in Newtown Square, Pennsylvania (excluding reasonable business related travel as
required by the Company's business); or (5) any other material breach of this
Agreement by the Company, which breach is not cured within 14 days after written
notice of such breach is delivered by Executive to the Company.

         5. Effect of Termination.

                  5.1      Expiration of Term.

                           (a) If Executive elects not to renew Executive's
employment for any Additional Term under Section 4.1, the Company will pay to
Executive the base salary and benefits otherwise payable to Executive under
Sections 3.1, 3.2 and 3.4, pro rata through the last day of Executive's actual
employment by the Company.

                           (b) If the Company elects not to renew Executive's
employment for any Additional Term under Section 4.1, the Company will pay to
Executive (1) severance equal to 18 months of base salary then applicable under
Section 3.1 in the manner provided under Section 3.2, (2) an amount equal to two
times the average, and if necessary annualized, Bonus paid to Executive for the
most recent two years of the Initial Term or Additional Term in the manner
provided under Section 3.2 (with the intent of this Section 5.1(b)(2) being that
the Company will pay Executive Bonus for the six months notice period under
Section 2.1 and the 18 months severance period under Section 5.1(b)(1)), and (3)
for the period that Executive is receiving severance, an additional amount equal
to the Company's then applicable contribution to Executive's standard full-time
health benefits, or, if greater, the amount Executive would be required to pay
to maintain full-time health benefits under COBRA. Executive is not required to
mitigate damages to receive the payments set forth in this Section 5.1(b).

                  5.2 Termination for Cause. If the Company terminates
Executive's employment for cause under Section 4.2, the Company will pay to
Executive the base salary and benefits otherwise payable to Executive under
Sections 3.1, 3.2 and 3.4, pro rata through the last day of Executive's actual
employment by the Company.

                  5.3      Termination Without Cause.

                           (a) If the Company terminates Executive's employment
under Section 4.3 for any reason other than for cause at any time during the
Original Term or any Additional Term, the Company will pay to Executive (1)
severance equal to 24 months of base salary then applicable under Section 3.1 in
the manner provided under Section 3.2, (2) an amount equal to two times the
average, and if necessary annualized, Bonus paid to Executive for the most
recent two years of the Initial Term or Additional Term in the manner provided
under Section 3.2, and (3) for the period that Executive is receiving severance,
an additional amount equal to the Company's then applicable contribution to
Executive's standard full-time health benefits or, if greater, the amount
Executive would be required to pay to maintain full-time health benefits under
COBRA.

                                       5
<PAGE>

                           (b) Executive acknowledges that if Executive's
employment is terminated pursuant to Section 4.3, the payment in full of the
severance, and payments on account of the Bonus and health benefits under this
Section 5.3 and the provisions regarding his stock options in Section 3.3,
represent the total obligation of the Company to Executive under this Agreement.
Further, Executive is not required to mitigate damages to receive the payments
set forth in Section 5.3(a).

                  5.4 Termination for Death or Disability. If Executive's
employment is terminated by death or because of disability under Section 4.4,
the Company will pay to the estate of Executive or to Executive, as applicable,
the base salary and benefits otherwise payable to Executive under Sections 3.1,
3.2 and 3.4 through the end of the month in which termination of Executive's
employment because of death or disability occurs.

                  5.5      Termination by Executive.

                           (a) If Executive terminates Executive's employment
under Section 4.5(a) for reasons of health, the Company will pay to Executive
the base salary and benefits otherwise payable to Executive under Sections 3.1,
3.2 and 3.4, pro rata through the date of termination.

                           (b) If Executive terminates Executive's employment
under Section 4.5(b) for good reason at any time during the Original Term or any
Additional Term, the Company will pay to Executive (1) severance equal to 24
months of base salary then applicable under Section 3.1 in the manner provided
under Section 3.2, (2) an amount equal to two times the average, and if
necessary annualized, Bonus paid to Executive for the most recent two years of
the Initial Term or Additional Term in the manner provided under Section 3.2,
and (3) for the period that Executive is receiving severance, an additional
amount equal to the Company's then applicable contribution to Executive's
standard full-time health benefits or, if greater, the amount Executive would be
required to pay to maintain full-time health benefits under COBRA.

                           (c) Executive acknowledges that if Executive's
employment is terminated pursuant to Section 4.5(b), the payment in full of the
severance, and payments on account of bonus and health benefits under Section
5.5(b) and the provisions regarding his stock options in Section 3.3, represent
the total obligation of the Company to Executive under this Agreement. Further,
Executive is not required to mitigate damages to receive the payments set forth
in Section 5.5(b).

                           (d) If Executive terminates Executive's employment
under Section 4.5(c), the Company will pay to Executive the base salary and
benefits otherwise payable to him under Sections 3.1, 3.2 and 3.4, pro rata
through the last day of his actual employment by the Company.

                                       6
<PAGE>

                  5.6      Gross-Up Payment.

                           (a) If it is determined that any payment or
distribution by the Company to or for the benefit of Executive, whether paid or
payable or distributed or distributable under this Agreement or otherwise (the
"Payment"), would constitute an "excess parachute payment" within the meaning of
Section 280G of the Code, the Company will pay Executive an additional amount
(the "Gross-Up Payment") such that the net amount retained by Executive after
deduction of any excise tax imposed under Section 4999 of the Code, and any
Federal, state and local income and employment tax and excise tax imposed upon
the Gross-Up Payment is equal to the Payment. For purposes of determining the
amount of the Gross-Up Payment, Executive will be deemed to pay Federal income
tax and employment taxes at the highest marginal rate of Federal income and
employment taxation in the calendar year in which the Gross-Up Payment is to be
made (currently, 35% and 7.65%, respectively) and state and local income taxes
at the highest marginal rate of taxation applicable to personal service income
in the state and locality of Executive's residence on the date Executive's
employment terminates, net of the maximum reduction in Federal income taxes that
may be obtained from the deduction of such state and local taxes and without
regard to any other items of income, gain, loss, deduction or credit of
Executive.

                           (b) The firm charged with preparing the Company's tax
returns immediately prior to the Change of Control (the "Accounting Firm") will
make calculations required under this Section 5.6, and the Company will provide
the result of such calculations and supporting documentation to Executive
promptly following Executive's termination of employment. The Accounting Firm's
determination will be binding upon the Company and Executive. The Company or its
successor will pay Executive the Gross-up Payment no later than the tenth day
after the date on which it forwards the results of the Accounting Firm's
determination to Executive.

                           (c) Executive must notify the Company in writing of
any claim by the Internal Revenue Service that, if successful, would require the
payment by the Company of the Gross-Up Payment. Such notice must be given as
soon as practicable but no later than ten business days after Executive knows of
such claim and must apprise the Company of the nature of such claim and the date
on which such claim is requested to be paid. Executive will not pay such claim
prior to the expiration of the 30-day period following the date on which it
gives such notice to the Company (or such shorter period ending on the date that
any payment of taxes with respect to such claim is due). If the Company notifies
Executive in writing prior to the expiration of such period that it desires to
contest such claim, Executive will:

                                     (i) give the Company any information
reasonably requested by the Company relating to such claim;

                                     (ii) take such action in connection with
contesting such claim as the Company may reasonably request in writing from time
to time, including, without limitation, accepting legal representation with
respect to such claim by an attorney reasonably selected by the Company;

                                     (iii) cooperate with the Company in good
faith in order to effectively contest such claim, and

                                       7
<PAGE>

                                     (iv) permit the Company to participate in
any proceedings relating to such claim.

                           (d) The Company will pay directly all costs and
expenses (including additional interest and penalties) incurred in connection
with the Internal Revenue Service claim under Section 5.6(c). The Company will
also control all proceedings taken in connection with such claim and, at its
sole option, may pursue or forego any and all administrative appeals,
proceedings, hearing and conferences with the taxing authority in respect of
such claim and may, at its sole option, either direct Executive to pay the tax
claimed and sue for a refund or contest the claim in any permissible manner, and
Executive agrees to prosecute such contest to a termination before any
administrative tribunal, in a court of initial jurisdiction and in one or more
appellate courts, as the Company may determine. If the Company directs Executive
to pay such claim and sue for a refund, the Company shall advance the amount of
such payment to Executive on an interest-free basis.

                           (e) If, after the receipt by Executive of an amount
advanced by the Company pursuant to this Section 5.6, Executive becomes entitled
to receive any refund with respect to such claim, Executive will (subject to the
Company's complying with the requirements of Section 5.6(c)) promptly pay to the
Company the amount of such refund (together with any interest paid or credited
thereon after taxes applicable thereto). If, after the receipt by Executive of
an amount advanced by the Company pursuant to this Section 5.6, a determination
is made that Executive is not entitled to any refund with respect to such claim
and the Company does not notify Executive in writing of its intent to contest
such denial of refund prior to the expiration of thirty days after such
determination, then such advance will be forgiven and will not be required to be
repaid and the amount of such advance will offset, to the extent thereof, the
amount of Gross-Up Payment required to be paid.

                           (f) All of the fees and expenses of the Accounting
Firm in performing the determinations referred to in Section 5.6(b) will be
borne solely by the Company.

                  5.7 Payment Timing. No payments to be made under this Section
5 will be made prior to the time permitted under Section 409A of the Code but
will be paid with interest at the applicable federal rate when the delayed
payments are permissible.

         6. Non-Competition, Non-Solicitation and Confidentiality.

                  6.1 Non-Competition. During the Original Term and, if
automatically renewed, any Additional Term (regardless whether the Original Term
or any Additional Term is terminated under Section 4 prior to its scheduled
expiration under Section 1) and during the Post Expiration Non-Competition
Period (as defined below) after the expiration of the Original Term and, if
automatically renewed, any Additional Term, Executive will not, including
through an Affiliate (as defined in Rule 12b-2 promulgated pursuant to the
Securities Exchange Act of 1934, as amended), directly engage in the primary
business of offering on-site occupational health, primary care, corporate
health, disease management and pharmacy services to self-insured employers (the
"Business") in the United States. Each of the following activities, without
limitation, are deemed to constitute engaged in the Business: engaging in,
working with, maintaining an interest in (other than interests of less than 1%

                                       8
<PAGE>

in companies with securities traded either on the New York Stock Exchange, the
American Stock Exchange, the Nasdaq National Market, the Nasdaq SmallCap Market
or traded over-the-counter and quoted on the Bulletin Board), advising for a fee
or other consideration, managing, operating, lending money to (other than loans
by commercial banks), guaranteeing the debts or obligations of, or permitting
one's name or any part thereof to be used in connection with an enterprise or
endeavor, either individually, in partnership or in conjunction with any
individual, partnership, corporation, limited liability company, association,
joint stock company, trust, joint venture or any other form of business
organization, unincorporated organization or governmental entity (or any
department, agency or subdivision thereof) (each, a "Person"), whether as
principal, director, agent, shareholder, partner, employee, consultant,
independent contractor or in any other manner whatsoever, any Person in the
Business. "Post Expiration Non-Competition Period" means the longer of one year
and the period during which Executive is receiving severance under this
Agreement.

                  6.2 Non-solicitation. During the Original Term and, if
automatically renewed, any Additional Term (regardless whether the Original Term
or any Additional Term is terminated under Section 4 prior to its scheduled
expiration under Section 1) and during the Post Termination Non-Solicitation
Period (as defined below) after the expiration of the Original Term and, if
automatically renewed, any Additional Term, Executive will not, directly or
indirectly, and no Person (including an Affiliate) over which Executive
exercises control (whether as an officer, director, individual proprietor,
holder of debt or equity securities, consultant, partner, member or otherwise)
(a) solicit or engage or employ or otherwise enter into any agreement or
understanding, written or oral, relating to the services of any Person who is
known or should be known by Executive to be then employed or to have been
employed within the preceding six months by the Company or its Affiliates, (b)
take any action which could be reasonably expected to lead any Person to cease
to deal with the Company or its Affiliates or (c) solicit the business of, enter
into any written or oral agreement with or otherwise deal with any supplier of
goods, products, materials or services in competition with the Company or its
Affiliates or solicit the business of customers of the Company or its Affiliates
who were such at any time during the two-year period preceding Executive's last
date of employment, except on behalf of businesses in which such party would
then be permitted to engage directly without violating this Section 6. "Post
Expiration Non-Solicitation Period" means the longer of one year and the period
during which Executive is receiving severance under this Agreement.

                  6.3 Confidentiality. During the Original Term and, if
automatically renewed, any Additional Term (regardless whether the Original Term
or any Additional Term is terminated under Section 4 prior to its scheduled
expiration under Section 1) and for a period of five years after the expiration
of the Original Term and, if automatically renewed, any Additional Term,
Executive will treat as trade secrets all Confidential Information (as defined
below) known or acquired by Executive in the course of any affiliation Executive
has with the Company or its Affiliates and will not disclose any Confidential
Information to any Person not affiliated with the Company except as authorized
in writing by the Company. "Confidential Information" means any information
relating to the relationship of the Company or its Affiliates to their customers
(including, without limitation, the identity of any customer), the research,

                                       9
<PAGE>

design, development, manufacturing, marketing, pricing, costs, capabilities,
capacities and business plans related to the Business, the financing
arrangements of the Company, or the financial condition or prospects of the
Company; inventions, products, processes, methods, techniques, formulas,
compositions, compounds, projects, developments, plans, research data, clinical
data, financial data, personnel data, computer programs, software, including
source code, object code, operating systems, bridgeware, firmware, middleware or
utilities and customer and supplier lists and any other confidential information
relating to the assets, condition or business of the Company or its Affiliates.
Notwithstanding the foregoing, Executive will have no obligation with respect to
(a) information disclosed to Executive by a Person who does not owe a duty of
confidentiality to the Company or its Affiliates, or (b) information which is in
the public domain and is readily available, or (c) information where disclosure
is required by law or is necessary in connection with a claim, dispute or
litigation to which Executive is or becomes a party and the Company is given
such prior written notice of the intent to make disclosure as is reasonable
under the circumstances.

                  6.4 Injunctive Relief. The restrictions contained in this
Section 6 are necessary for the protection of the business and goodwill of the
Company and its Affiliates and are considered by Executive to be reasonable for
such purpose. Executive acknowledges that a breach or threatened breach by
Executive of the covenants contained in this Section 6 would cause the Company
irreparable harm and that the extent of damages to the Company would be
impossible to ascertain and that there is and will be available to the Company
no adequate monetary damages or other remedy at law to compensate it in the
event of any such breach. Consequently, in the event of a breach of any such
covenant, in addition to any other relief to which the Company is or may be
entitled, the Company may seek, as a matter of course, an injunction or other
equitable relief, including the remedy of specific performance, to enforce any
or all of such covenants by Executive, his or her employer, employees, partners,
agents or any of them.

                  6.5 Modification of Covenants. In the event an arbitrator,
court or governmental agency or authority determines that any provision of
Section 6 is invalid by reason of the length of any period of time or the size
of any area during or in which such provision is effective, such period of time
or area will be considered to be reduced to the extent required to cure such
invalidity.

                  6.6 Extension of Covenant. In the event Executive violates the
restrictions contained in Section 6.1, the duration of such restriction will
extend for a period of time equal to the period of time during which such
violation continued.

                  6.7 Counter-claims. Any claim or cause of action by Executive
against the Company, whether predicated on this Agreement or otherwise, will not
constitute a defense to the enforcement by the Company of the restrictions
contained in this Section 6, but will be litigated separately including, without
limitation, any claim by Executive that Executive has not been terminated for
cause pursuant to Section 4.2, unless the claim and defense arise out of the
same event and joinder would be required.

                                       10
<PAGE>

         7. Inventions, Patents and Intellectual Property.

                  7.1 Executive agrees that all inventions, discoveries,
computer programs, data, software, technology, designs, innovations and
improvements (whether or not patentable and whether or not copyrightable)
(individually, an "Invention," and collectively, "Inventions") related to the
Business which are made, conceived, reduced to practice, created, written,
designed or developed by Executive, solely or jointly with others and whether
during normal business hours or otherwise, during the Original Term, any
Additional Term or thereafter if resulting or directly derived from Confidential
Information, will be the sole property of the Company. Executive hereby assigns
to the Company all Inventions and any and all related patents, copyrights,
trademarks, trade names, and other industrial and intellectual property rights
and applications therefor, in the United States and elsewhere and appoints any
officer of the Company as Executive's duly authorized attorney to execute, file,
prosecute and protect the same before any government agency, court or authority.
Upon the request of the Company and at the Company's expense, Executive will
execute such further assignments, documents and other instruments as may be
necessary or desirable to fully and completely assign all Inventions to the
Company and to assist the Company in applying for, obtaining and enforcing
patents or copyrights or other rights in the United States and in any foreign
country with respect to any Invention.

                  7.2 Executive will promptly disclose to the Company all
Inventions and will maintain adequate and current written records (in the form
of notes, sketches, drawings and as may be specified by the Company) to document
the conception and/or first actual reduction to practice of any Invention. Such
written records will be available to and remain the sole property of the Company
at all times.

         8. Return of Confidential Information. All files, letters, memoranda,
reports, records, data, sketches, drawings, laboratory notebooks, program
listings or other written, photographic or other tangible material, in each
event, containing Confidential Information, whether created by Executive or
others, which come into Executive's custody or possession, are and will be the
exclusive property of the Company to be used by Executive only in the
performance of his duties for the Company.

         9. Cooperation. At any time during the term of this Agreement or
thereafter, Executive will reasonably cooperate with the Company in any
litigation or administrative proceedings involving any matters with which
Executive was involved during Executive's employment by the Company. The Company
will reimburse Executive for reasonable expenses, if any, incurred in providing
such cooperation.

         10. Notices. All notices, requests, demands and other communications
required or permitted under this Agreement must be in writing, and may be given
by a party hereto by (a) personal service (effective upon delivery), (b) mailed
by registered or certified mail, return receipt requested, postage prepaid
(effective five business days after dispatch), (c) reputable overnight delivery
service, charges prepaid (effective the next business day), or (d) telecopy or
other means of electronic transmission (effective upon receipt of the telecopy
or other electronic transmission in complete, readable form), if confirmed

                                       11
<PAGE>

promptly by any of the methods specified in Sections 10(a)-(c), to the other
party at the address shown above, or at such other address or addresses as
either party may designate to the other in accordance with this Section 10.

         11. Non-Disparagement. During the term of Executive's employment
hereunder and for five years thereafter, neither party (including the Company's
officers, employees and directors) will disparage, deprecate, or make any
negative comment with respect to the other (including Affiliates of the Company)
or their respective businesses, operations, or properties.

         12. Pronouns. Whenever the context may require, any pronouns used in
this Agreement include the corresponding masculine, feminine or neuter forms,
and the singular forms of nouns and pronouns include the plural and vice versa.

         13. Entire Agreement. This Agreement, and such other agreements,
schedules and exhibits as are referenced in this Agreement, constitute the
entire agreement between the parties and supersede all prior agreements and
understandings, whether written or oral, relating to the subject matter of this
Agreement.

         14. Amendment. This Agreement may be amended or modified only by a
written instrument executed by both the Company and Executive.

         15. Governing Law; Consent to Jurisdiction.

                  15.1 This Agreement shall be construed, interpreted and
enforced in accordance with the laws of the Commonwealth of Pennsylvania,
notwithstanding any contrary application of conflicts of laws principles.

                  15.2 Each of the Company and Executive consents to the
jurisdiction of all Federal and state courts located in the Commonwealth of
Pennsylvania which have jurisdiction over any disputes arising under this
Agreement. Service of process in any action or proceeding commenced in a court
located in the Commonwealth of Pennsylvania may be made by written notice as
provided in Section 10.

         16. Successors and Assigns. This Agreement will be binding upon and
inure to the benefit of both parties and their respective successors and
assigns, including any corporation with which or into which the Company may be
merged or which may succeed to its assets or business; provided, however, that
the obligations of Executive are personal and may not be assigned by him.

         17.      Miscellaneous.

                  17.1 No delay or omission by the Company in exercising any
right under this Agreement operates as a waiver of that or any other right. A
waiver or consent given by the Company on any one occasion is effective only in
that instance and will not be construed as a bar or waiver or any right on any
other occasion.

                                       12
<PAGE>

                  17.2 The captions of the sections of this Agreement are for
convenience of reference only and in no way define, limit or affect the scope or
substance of any section of this Agreement.

                  17.3 In case any provision of this Agreement is invalid,
illegal or otherwise unenforceable, the validity, legality and enforceability of
the remaining provisions will in no way be affected or impaired.

                  17.4 During the Original Term, any Additional Term and for a
period of not less than six years after Executive's termination for any reason,
Executive will be entitled to indemnification and, to the extent available on
commercially reasonable terms, insurance coverage therefor, with respect to any
liabilities to the fullest extent as to which directors and officers of the
Company may be indemnified pursuant to the Company's bylaws or the laws of the
State of Delaware.

         IN WITNESS WHEREOF, the parties hereto, intending to be legally bound,
have executed this Agreement as of the day and year set forth above.

                                           COMPANY:

                                           I-TRAX, INC.

                                           By: /s/ Frank A. Martin
                                              --------------------------------
                                                 Name:  Frank A. Martin
                                                 Title: Chairman

                                           Attest: /s/ Yuri Rozenfeld
                                                  ----------------------------
                                                    Name:  Yuri Rozenfeld
                                                    Title: Secretary

                                           EXECUTIVE:

Witness: illegible                         Raymond J. Fabius
        ----------------------             -----------------------------

                                       13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]